Mirati Therapeutics, Inc. Peer Comparison
Metric | Value | Ranking | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $4.1 Billion | 5/12 | SRPT $10.5B |
MDGL $7.4B |
RETA $6.6B |
KRYS $4.4B |
MRTX $4.1B |
PTCT $3.8B |
APLS $3.5B |
VKTX $3.3B |
DAWN $1.2B |
ICPT $794.7M |
TERN $368.6M |
HEPA $2.1M |
Gross Margin | 91% | 6/12 | ICPT 100% |
MDGL 97% |
RETA 96% |
PTCT 92% |
DAWN 92% |
MRTX 91% |
KRYS 90% |
APLS 81% |
SRPT 80% |
VKTX 0% |
HEPA 0% |
TERN 0% |
Profit Margin | -100% | 11/12 | RETA 100% |
DAWN 100% |
KRYS 32% |
SRPT 7% |
VKTX 0% |
HEPA 0% |
TERN 0% |
ICPT -3% |
APLS -33% |
PTCT -79% |
MRTX -100% |
MDGL -100% |
EBITDA margin | -1049% | 12/12 | DAWN 148% |
KRYS 27% |
SRPT 5% |
ICPT -3% |
APLS -38% |
PTCT -40% |
VKTX -100% |
HEPA -100% |
TERN -100% |
MDGL -166% |
RETA -356% |
MRTX -1049% |
Quarterly Revenue | $16.4 Million | 9/12 | SRPT $467.2M |
APLS $176.6M |
PTCT $135.4M |
ICPT $88.8M |
KRYS $83.8M |
MDGL $62.2M |
RETA $22.7M |
DAWN $20.1M |
MRTX $16.4M |
VKTX $0 |
HEPA $0 |
TERN $0 |
Quarterly Earnings | -$161.9 Million | 12/12 | RETA $193.0M |
DAWN $37.0M |
SRPT $33.6M |
KRYS $27.2M |
ICPT -$2.8M |
HEPA -$4.9M |
TERN -$21.9M |
VKTX -$24.9M |
APLS -$57.4M |
PTCT -$106.7M |
MDGL -$107.0M |
MRTX -$161.9M |
Quarterly Free Cash Flow | -$143.7 Million | 12/12 | KRYS $57.8M |
APLS $34.1M |
ICPT $3.9M |
HEPA -$2.5M |
DAWN -$5.0M |
TERN -$16.5M |
VKTX -$22.0M |
PTCT -$22.8M |
MDGL -$62.8M |
RETA -$70.2M |
SRPT -$98.0M |
MRTX -$143.7M |
Trailing 4 Quarters Revenue | $38.2 Million | 7/12 | SRPT $1.6B |
PTCT $839.3M |
APLS $675.9M |
ICPT $317.7M |
KRYS $241.5M |
MDGL $76.8M |
MRTX $38.2M |
DAWN $28.8M |
RETA $24.4M |
VKTX $0 |
HEPA $0 |
TERN $0 |
Trailing 4 Quarters Earnings | -$716.6 Million | 12/12 | SRPT $467.2M |
APLS $176.6M |
PTCT $135.4M |
ICPT $88.8M |
KRYS $83.8M |
MDGL $62.2M |
RETA $22.7M |
DAWN $20.1M |
MRTX $16.4M |
VKTX -$0 |
HEPA -$0 |
TERN -$0 |
Quarterly Earnings Growth | 7% | 9/12 | RETA 362% |
SRPT 182% |
KRYS 182% |
DAWN 180% |
APLS 59% |
HEPA 54% |
TERN 26% |
PTCT 20% |
MRTX 7% |
MDGL -8% |
VKTX -11% |
ICPT -101% |
Annual Earnings Growth | -2% | 8/12 | SRPT 208% |
KRYS 133% |
RETA 72% |
HEPA 57% |
APLS 51% |
DAWN 50% |
PTCT 38% |
MRTX -2% |
TERN -6% |
VKTX -24% |
MDGL -46% |
ICPT -124% |
Quarterly Revenue Growth | 202% | 2/12 | RETA 2885% |
MRTX 202% |
APLS 78% |
SRPT 41% |
ICPT 14% |
VKTX 0% |
MDGL 0% |
KRYS 0% |
HEPA 0% |
TERN 0% |
DAWN 0% |
PTCT -31% |
Annual Revenue Growth | 77% | 2/12 | RETA 596% |
MRTX 77% |
APLS 76% |
SRPT 47% |
ICPT 8% |
VKTX 0% |
MDGL 0% |
PTCT 0% |
KRYS 0% |
HEPA 0% |
TERN 0% |
DAWN 0% |
Cash On Hand | $258.7 Million | 6/12 | PTCT $526.0M |
DAWN $422.8M |
APLS $396.9M |
KRYS $374.0M |
TERN $270.1M |
MRTX $258.7M |
MDGL $232.7M |
SRPT $197.9M |
ICPT $102.7M |
VKTX $50.3M |
RETA $48.8M |
HEPA $1.5M |
Short Term Debt | $8.0 Million | 3/12 | SRPT $91.6M |
PTCT $16.8M |
MRTX $8.0M |
APLS $6.8M |
RETA $2.5M |
HEPA $2.2M |
KRYS $1.3M |
MDGL $878,000 |
VKTX $480,000 |
TERN $272,000 |
DAWN $77,000 |
ICPT -$0 |
Long Term Debt | $42.2 Million | 7/12 | SRPT $1.3B |
PTCT $383.5M |
ICPT $223.9M |
RETA $163.5M |
MDGL $118.3M |
APLS $104.7M |
MRTX $42.2M |
DAWN $2.5M |
TERN $1.0M |
VKTX $755,000 |
KRYS $0 |
HEPA $0 |
PE | -1.00 | 3/12 | SRPT 86.01 |
KRYS 83.10 |
MRTX -1.00 |
VKTX -1.00 |
RETA -1.00 |
ICPT -1.00 |
MDGL -1.00 |
PTCT -1.00 |
APLS -1.00 |
HEPA -1.00 |
TERN -1.00 |
DAWN -1.00 |
PS | 107.82 | 2/12 | RETA 269.17 |
MRTX 107.82 |
MDGL 96.59 |
DAWN 42.44 |
KRYS 18.02 |
SRPT 6.39 |
APLS 5.25 |
PTCT 4.50 |
ICPT 2.50 |
VKTX -1.00 |
HEPA -1.00 |
TERN -1.00 |
PB | 4.35 | 7/12 | RETA 75.22 |
APLS 14.96 |
ICPT 11.06 |
MDGL 9.55 |
SRPT 8.58 |
KRYS 4.91 |
MRTX 4.35 |
VKTX 3.66 |
DAWN 2.20 |
TERN 1.01 |
PTCT 0.00 |
HEPA 0.00 |
PC | 15.92 | 5/12 | RETA 134.44 |
VKTX 66.31 |
SRPT 52.97 |
MDGL 31.89 |
MRTX 15.92 |
KRYS 11.64 |
APLS 8.94 |
ICPT 7.74 |
PTCT 7.17 |
DAWN 2.89 |
HEPA 1.42 |
TERN 1.36 |
Liabilities to Equity | 0.19 | 6/12 | RETA 4.76 |
ICPT 4.47 |
APLS 2.80 |
SRPT 1.95 |
MDGL 0.38 |
MRTX 0.19 |
KRYS 0.11 |
DAWN 0.08 |
TERN 0.04 |
VKTX 0.03 |
PTCT 0.00 |
HEPA 0.00 |
ROA | -0.63 | 11/12 | KRYS 5% | SRPT 3% | VKTX -11% | ICPT -15% | DAWN -15% | RETA -16% | TERN -23% | PTCT -25% | APLS -28% | MDGL -48% | MRTX -63% | HEPA -611% |
ROE | -0.76 | 9/12 | HEPA 5583% |
PTCT 43% |
SRPT 10% |
KRYS 6% |
VKTX -11% |
DAWN -16% |
TERN -24% |
MDGL -67% |
MRTX -76% |
ICPT -82% |
RETA -94% |
APLS -105% |
Current Ratio | 6.17 | 5/12 | VKTX 35.47 |
TERN 27.48 |
DAWN 13.25 |
KRYS 10.18 |
MRTX 6.17 |
MDGL 3.62 |
SRPT 1.51 |
APLS 1.36 |
ICPT 1.22 |
RETA 1.21 |
HEPA 0.90 |
PTCT 0.64 |
Quick Ratio | 5.33 | 5/12 | SRPT 86.01 |
KRYS 83.10 |
MRTX -1.00 |
VKTX -1.00 |
RETA -1.00 |
ICPT -1.00 |
MDGL -1.00 |
PTCT -1.00 |
APLS -1.00 |
HEPA -1.00 |
TERN -1.00 |
DAWN -1.00 |
Long Term Debt to Equity | 0.04 | 6/12 | ICPT} 3.12 |
RETA} 1.87 |
SRPT} 1.07 |
APLS} 0.44 |
MDGL} 0.15 |
MRTX} 0.04 |
VKTX} 0.00 |
KRYS} 0.00 |
HEPA} 0.00 |
TERN} 0.00 |
DAWN} 0.00 |
PTCT} -0.36 |
Debt to Equity | 0.05 | 5/12 | ICPT 3.12 |
RETA 1.90 |
SRPT 1.14 |
APLS 0.47 |
MRTX 0.05 |
VKTX 0.00 |
MDGL 0.00 |
KRYS 0.00 |
TERN 0.00 |
DAWN 0.00 |
PTCT -0.38 |
HEPA -5.47 |
Burn Rate | 1.56 | 8/12 | TERN 12.25 |
ICPT 8.75 |
APLS 6.27 |
SRPT 4.76 |
PTCT 4.17 |
MDGL 2.08 |
VKTX 2.01 |
MRTX 1.56 |
HEPA 0.28 |
RETA -0.26 |
DAWN -11.45 |
KRYS -13.92 |
Cash to Cap | 0.06 | 8/12 | TERN 0.73 |
HEPA 0.70 |
DAWN 0.35 |
PTCT 0.14 |
ICPT 0.13 |
APLS 0.11 |
KRYS 0.09 |
MRTX 0.06 |
MDGL 0.03 |
VKTX 0.02 |
SRPT 0.02 |
RETA 0.01 |
CCR | 0.89 | 2/12 | KRYS 2.13 |
MRTX 0.89 |
VKTX 0.88 |
TERN 0.75 |
MDGL 0.59 |
HEPA 0.52 |
PTCT 0.21 |
DAWN -0.13 |
RETA -0.36 |
APLS -0.59 |
ICPT -1.38 |
SRPT -2.91 |
EV to EBITDA | -22.72 | 7/12 | SRPT} 526.23 |
KRYS} 177.39 |
DAWN} 27.10 |
VKTX} -1.00 |
HEPA} -1.00 |
TERN} -1.00 |
MRTX} -22.72 |
APLS} -48.28 |
PTCT} -66.92 |
MDGL} -69.79 |
RETA} -82.50 |
ICPT} -331.82 |
EV to Revenue | 102.36 | 2/12 | RETA 273.97 |
MRTX 102.36 |
MDGL 93.57 |
DAWN 27.86 |
KRYS 16.48 |
SRPT 7.12 |
APLS 4.82 |
PTCT 4.35 |
ICPT 2.88 |
VKTX -1.00 |
HEPA -1.00 |
TERN -1.00 |